The expression levels of TPGRL1 and TYROBP and IL-8 and TNF-α increased for diabetic patients, whereas TYROBP and USP16 and IL-6, IL-8, CSF2, and TNF-α increased for multiple sclerosis patients. Here, TYROBP is linked to multiple sclerosis.